Increased red blood cell aggregation in patients with Gaucher disease is non-inflammatory

Clinical Hemorheology and Microcirculation

Volumn 40, Issue 2, 2008, Pages 113-118

  Adar, T ^a   Ben Ami, R ^b   Elstein, D ^a   Zimran, P ^a   Berliner, S ^b   Yedgar, S ^c   Barshtein, G ^c  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

Gaucher disease; Red blood cells aggregation

Indexed keywords

FIBRINOGEN;

ARTICLE; BLOOD RHEOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REPLACEMENT; ERYTHROCYTE AGGREGATION; FIBRINOGEN BLOOD LEVEL; GAUCHER DISEASE; HUMAN; HUMAN CELL; INFLAMMATION; PRESSURE GRADIENT; SHEAR STRESS;

BONE DISEASES; ERYTHROCYTE AGGREGATION; FIBRINOGEN; GAUCHER DISEASE; GLUCOSYLCERAMIDES; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; NECROSIS;

EID: 57049138312     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1121     Document Type: Article

References (17)

1. T.V. Korotaeva, N.N. Firsov, A. Bjelle and M.A. Vishlova, Erythrocytes aggregation in healthy donors at native and standard hematocrit: the influence of sex, age, immunoglobulins and fibrinogen concentrations. Standardization of parameters, Clin. Hemorheol. Microcirc. 36 (2007), 335-343.
2. S. Shin, M.S. Park, Y.H. Ku and J.S. Suh, Shear-dependent aggregation characteristics of red blood cells in a pressuredriven microfluidic channel, Clin. Hemorheol. Microcirc. 34 (2006), 353-361.
3. R. Ben-Ami, G. Barshtein, T. Mardi, V. Deutch, O. Elkayam, S. Yedgar and S. Berliner, A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation, Am. J. Physiol. Heart Circ. Physiol. 285 (2003), 2663-2669.
4. G. McHedlishvili, M. Varazashvili and L. Gobejishvili, Local RBC aggregation disturbing blood fluidity and causing stasis in microvessels, Clin. Hemorheol. Microcirc. 26 (2002), 99-106.
5. E. Beutler and G.A. Grabowski, Gaucher disease, in: The Metabolic and Molecular Bases of Inherited Diseases, C.R. Scriver, D. Valle, A. Beudet and W.S. Sly, eds, McGraw-Hill, New York, 2001, pp. 3635-3668.
6. G.A. Grabowski and M. Horowitz, Gaucher's disease: molecular, genetic and enzymological aspects, Baillieres Clin. Haematol. 10 (1997), 635-656.
7. N.W. Barton, R.O. Brady, J.M. Dambrosia, A.M. Di Bisceglie, S.H. Doppelt, S.C. Hil, H.J. Mankin, G.J. Murray, R.I. Parker, C.E. Argoff et al., Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher's disease, N. Engl. J. Med. 324 (1991), 1464-1470.
8. O. Rogowski, I. Shapira, A. Zimran, D. Zeltser, D. Elstein, D. Attias, A. Bashkin and S. Berliner, Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model, Blood Cells Mol. Dis. 34 (2005), 26-29.
9. M.J. Allen, B.J. Myer, N. Khokher, N. Rushton and T.M. Cox, Pro-inflamatory cytokines and the pathogenesis of Gaucher's disease: increased release of inteleukin-6 and interleukin-10, Q. J. Med. 90 (1997), 19-25.
10. D. Elstein, A. Nir, M. Klutstein, B. Rudensky and A. Zimran, C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease, Blood Cells Mol. Dis. 34 (2005), 201-205.
11. D. Shitrit, B. Rudensky, A. Zimran and D. Elstein, D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvement, Am. J. Hematol. 73 (2003), 236-239.
12. T. Adar, R. Ben-Ami, D. Elstein, A. Zimran, S. Berliner, S. Yedgar and G. Barshtein, Aggregation of red blood cells in patients with Gaucher disease, Br. J. Hematol. 134 (2006), 432-437.
13. N.H. Cho, D.J. Becker, D. Ellis, L.H. Kuller, A.L. Drash and T.J. Orchard, Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study, J. Diabetes Complications 6 (1992), 12-18.
14. M. Margalit, S.A. Ghazala, R. Alper, E. Elinav, A. Klein, V. Doviner, Y. Sherman, B. Thalenfeld, D. Engelhardt, E. Rabbani and Y. Ilan, Glucocerebroside treatment ameliorates Con-A hepatitis by inhibition of NKT lymphocytes, Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005), 917-925.
15. S. Chen, G. Barshtein, B. Gavish, Y. Mahler and S. Yedgar, Monitoring of red blood cell aggregability in a flow-chamber by computerized image analysis, Clin. Hemorheol. 14 (1994), 497-508.
16. O. Nilsson, G. Hakansson, S. Dreborg, C.G. Groth and L. Svennerholm, Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III, Clin. Genet. 22 (1982), 274-279.
17. M. Margalit, Z. Shalev, O. Pappo, M. Sklair-Levi, R. Alper, M. Gomori, D. Engelharedt, E. Rabbani and Y. Ilan, Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice, J. Pharmacol. Exp. Ther. 319 (2006), 105-110.